DI BARTOLOMEO, MARIA CRISTINA
 Distribuzione geografica
Continente #
AS - Asia 1.274
EU - Europa 1.271
NA - Nord America 1.203
SA - Sud America 111
AF - Africa 55
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.922
Nazione #
US - Stati Uniti d'America 1.161
DE - Germania 502
CN - Cina 394
SG - Singapore 337
GB - Regno Unito 210
IT - Italia 180
BD - Bangladesh 148
VN - Vietnam 114
HK - Hong Kong 109
BR - Brasile 89
SE - Svezia 87
RU - Federazione Russa 68
FR - Francia 53
IN - India 42
CI - Costa d'Avorio 38
IE - Irlanda 37
NL - Olanda 35
FI - Finlandia 31
CA - Canada 25
JP - Giappone 25
ID - Indonesia 23
TR - Turchia 21
KR - Corea 14
ES - Italia 12
UA - Ucraina 12
IQ - Iraq 11
BE - Belgio 9
AR - Argentina 7
DK - Danimarca 7
EC - Ecuador 7
PL - Polonia 7
AU - Australia 6
MX - Messico 6
NO - Norvegia 6
PH - Filippine 4
AZ - Azerbaigian 3
DZ - Algeria 3
IR - Iran 3
JO - Giordania 3
KE - Kenya 3
PT - Portogallo 3
ZA - Sudafrica 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AT - Austria 2
CH - Svizzera 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
HU - Ungheria 2
KZ - Kazakistan 2
LB - Libano 2
MY - Malesia 2
NP - Nepal 2
PE - Perù 2
SV - El Salvador 2
TH - Thailandia 2
TN - Tunisia 2
TW - Taiwan 2
UY - Uruguay 2
UZ - Uzbekistan 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BS - Bahamas 1
BW - Botswana 1
CO - Colombia 1
DM - Dominica 1
EG - Egitto 1
ET - Etiopia 1
GE - Georgia 1
GY - Guiana 1
HN - Honduras 1
IS - Islanda 1
KG - Kirghizistan 1
LC - Santa Lucia 1
MA - Marocco 1
MN - Mongolia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PR - Porto Rico 1
PY - Paraguay 1
RO - Romania 1
SA - Arabia Saudita 1
SN - Senegal 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZW - Zimbabwe 1
Totale 3.922
Città #
Frankfurt am Main 439
Ashburn 185
Singapore 181
Southend 177
Hong Kong 93
Chandler 86
San Jose 74
Milan 67
Santa Clara 57
Beijing 56
New York 50
Dallas 44
Los Angeles 42
Abidjan 38
Council Bluffs 38
Fairfield 38
Dublin 37
Hanoi 36
Ho Chi Minh City 34
Seattle 29
Wilmington 27
Hefei 25
Munich 25
Princeton 25
Bengaluru 21
Buffalo 20
Helsinki 20
Cambridge 19
Houston 19
Istanbul 19
Jakarta 19
Dearborn 17
Shanghai 17
Woodbridge 17
Ann Arbor 16
Boardman 16
Lauterbourg 16
Nanjing 16
Tokyo 15
Moscow 14
Phoenix 14
Chicago 11
Columbus 10
Guangzhou 10
São Paulo 10
Des Moines 9
The Dalles 9
Toronto 9
Brussels 8
Nuremberg 8
Shenyang 8
Cangzhou 7
Jinan 7
Zhengzhou 7
Hangzhou 6
Mountain View 6
Naples 6
Oslo 6
Rome 6
Shenzhen 6
Tianjin 6
Wuhan 6
Amsterdam 5
Atlanta 5
Brasília 5
Da Nang 5
Grafing 5
Hebei 5
Hyderabad 5
Montreal 5
San Diego 5
Seoul 5
Stockholm 5
Sydney 5
Turku 5
Warsaw 5
Brooklyn 4
Chennai 4
Denver 4
Düsseldorf 4
Falls Church 4
San Francisco 4
Shijiazhuang 4
Taizhou 4
Urbino 4
Amman 3
Baku 3
Bari 3
Bến Tre 3
Central District 3
Changsha 3
Chengdu 3
Chongqing 3
Guayaquil 3
Handan 3
Hải Dương 3
Kent 3
Lanzhou 3
Manchester 3
McAllen 3
Totale 2.510
Nome #
Perioperative Bevacizumab-based Triplet Chemotherapy in Patients with Potentially Resectable Colorectal Cancer Liver Metastases 327
DPD and UGT1A1 deficiency in colorectal cancer patients receiving triplet chemotherapy with fluoropyrimidines, oxaliplatin and irinotecan 276
Prognostic impact of early tumor shrinkage and depth of response in patients with microsatellite instability-high metastatic colorectal cancer receiving immune checkpoint inhibitors 270
Maintenance Therapy with Panitumumab Alone vs Panitumumab Plus Fluorouracil-Leucovorin in Patients with RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial 266
Emergence of MET hyper-amplification at progression to MET and BRAF inhibition in colorectal cancer 263
ALK Inhibitors in Patients With ALK Fusion-Positive GI Cancers: An International Data Set and a Molecular Case Series 244
First-line anti-EGFR monoclonal antibodies in panRAS wild-type metastatic colorectal cancer : a systematic review and meta-analysis 241
Bax expression is predictive of favorable clinical outcome in chemonaive advanced gastric cancer patients treated with capecitabine, oxaliplatin, and irinotecan regimen 226
Impact of early tumor shrinkage and depth of response on the outcomes of panitumumab-based maintenance in patients with RAS wild-type metastatic colorectal cancer 224
Single-agent panitumumab in frail elderly patients with advanced RAS and BRAF wild-type colorectal cancer : challenging drug label to light up new hope 220
Reinduction of an Anti-EGFR-based First-line Regimen in Patients with RAS Wild-type Metastatic Colorectal Cancer Enrolled in the Valentino Study 218
Preoperative Capecitabine, Oxaliplatin, and Irinotecan in Resectable Gastric or Gastroesophageal Junction Cancer: Pathological Response as Primary Endpoint and FDG-PET Predictions 207
A review on biomarkers for prediction of treatment outcome in gastric cancer 202
Systemic doxycycline for pre-emptive treatment of anti-EGFR-related skin toxicity in patients with metastatic colorectal cancer receiving first-line panitumumab-based therapy: a post hoc analysis of the Valentino study 191
Transcriptional and epigenetic phenomena in peripheral blood cells of monozygotic twins discordant for Alzheimer’s disease, a case report 181
Prognostic value of diffuse versus intestinal histotype in patients with gastric cancer : a systematic review and meta-analysis 159
Translating knowledge into policy: Organizational model and minimum requirements for the implementation of a regional pancreas unit network 121
Impact of Metformin Use and Diabetic Status During Adjuvant Fluoropyrimidine-Oxaliplatin Chemotherapy on the Outcome of Patients with Resected Colon Cancer: A TOSCA Study Subanalysis 102
The potential role of metformin in the treatment of patients with pancreatic neuroendocrine tumors: a review of preclinical to clinical evidence 88
Totale 4.026
Categoria #
all - tutte 10.362
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.362


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022229 17 18 17 8 12 20 11 8 19 32 16 51
2022/2023290 31 40 29 24 17 61 7 16 39 1 18 7
2023/2024519 9 11 17 22 73 21 63 63 31 61 71 77
2024/2025757 57 76 51 90 41 41 41 52 27 75 69 137
2025/20261.620 159 120 146 140 118 73 210 35 127 106 242 144
2026/202729 29 0 0 0 0 0 0 0 0 0 0 0
Totale 4.026